Hoth Therapeutics, Inc.
Hoth Therapeutics, Inc. (HOTH) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
hoth · stock forecast · 4 analysts (3M) · FMP · updated Jun 9, 2026
Analyst Rating & Consensus
Based on 4 Wall Street analysts in the past 3 months
Buy
4 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$0.00
Consensus
$0.00
+0.0% upside
Low
$0.00
Median: $0 · Last Close: $1.39
Short-Term Price Prediction
Low ActivityAlgorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-10 | $1.39 | ↑ 0.00% |
1-day model range: $1.31–$1.47. Peak: $1.47 (+0.00%).
Long-Term Stock Price Prediction
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Insufficient Trading Activity — Sentiment Signals Disabled
This stock has very low trading volume (ZOMBIE condition). Sentiment analysis requires sufficient price action. RSI and MACD values below are still shown for reference.
Moving Averages · HOTH · Jun 9, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-03-25 | D. Boral Capital | Maintains | Buy→Buy |
| 2026-03-04 | D. Boral Capital | Maintains | Buy→Buy |
| 2025-12-04 | D. Boral Capital | Maintains | Buy→Buy |
| 2025-11-17 | D. Boral Capital | Maintains | Buy→Buy |
| 2025-08-18 | D. Boral Capital | Maintains | Buy→Buy |
| 2025-07-30 | D. Boral Capital | Maintains | Buy→Buy |
| 2025-07-23 | D. Boral Capital | Maintains | Buy→Buy |
| 2025-06-26 | D. Boral Capital | Maintains | Buy→Buy |
| 2025-06-12 | D. Boral Capital | Maintains | Buy→Buy |
| 2025-04-15 | D. Boral Capital | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Hoth Therapeutics, Inc. (HOTH) stock. Of the recent 29 rating actions, 0 were upgrades and 0 were downgrades. 4 analysts currently cover HOTH.
Analyst Recommendation Trends
HOTH analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 2 to 2 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$0M
Revenue Next Year
$0M
EPS This Year
$-0.59
EPS Next Year
$-0.70
↑ 18.4% YoY
EPS ForecastReported vs Estimated
Analysts forecast HOTH EPS of $-0.59 for the current fiscal year, based on estimates from 1 analysts. The HOTH revenue forecast is $0M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The HOTH stock forecast is supported by two independent data sources: analyst consensus ratings from 4 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus HOTH price target is $0.00 (+0.0% upside), with an analyst consensus of Buy.
The HOTH short-term stock prediction for tomorrow is $1.39 (+0.00%).
Hoth Therapeutics, Inc. trades on NASDAQ under the ticker HOTH. The HOTH stock outlook for 2027 is broadly positive, supported by a Buy consensus among 100% of covering analysts.
Frequently asked questions
HOTH forecast · 8 questionsAccording to 4 Wall Street analysts, the average 12-month HOTH price target is $0.00, with a high forecast of $0.00 and a low of $0.00. The median price target is shown in the chart above when available. This implies +0.0% potential upside from the current price of $1.39.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.